Background illustration for clinical trials search

Paid Clinical Trials Tempe

Discover 1,272 paid clinical trials in Tempe, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures

for
Focal Onset Seizure, Primary Generalized Epilepsy
Location: Phoenix AZ, Round Rock TX, Seabrook TX, Chesterfield MO,
Sponsor: Praxis Precision Medicines

Sex: All

Age: 18 - 70+

Code: NCT06908356

Phase2, Recruiting

A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer

for
HER2-positive Gastric Cancer,
Location: Phoenix AZ, La Jolla CA, Upland CA, Duarte CA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06764875

Phase3, Recruiting

AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)

for
Relapsed/Refractory Multiple Myeloma
Location: Phoenix AZ, La Jolla CA, Los Angeles CA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT05850234

Phase1, Phase2, Recruiting

A Platform Study in Non-Small Cell Lung Cancer (NSCLC)

for
Advanced or Metastatic Non-small Cell Lung Cancer
Location: Phoenix AZ, Santa Rosa CA, Tyler TX, Rochester MN,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06996782

Phase1, Phase2, Recruiting

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

for
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma,
Location: Phoenix AZ, Lone Tree CO, Walnut Creek CA, Dallas TX,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07431281

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)

for
Biliary Tract Cancer
Location: Phoenix AZ, Tucson AZ, Orange CA, Duarte CA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07221253

Phase3, Recruiting

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

for
Prostate Cancer
Location: Phoenix AZ, San Diego CA, La Jolla CA, Los Angeles CA,
Sponsor: AstraZeneca

Sex: Male

Age: 18+

Code: NCT06952803

Phase3, Recruiting

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

for
Hepatocellular Carcinoma
Location: Phoenix AZ, Tucson AZ, Los Angeles CA, Amarillo TX,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06921785

Phase3, Recruiting

Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation

for
Delayed Graft Function, DGF, Kidney Transplant
Location: Phoenix AZ, Los Angeles CA, Stanford CA,
Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT06830798

Phase3, Recruiting

Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC

for
Hepatocellular Carcinoma (HCC)
Location: Phoenix AZ, Tucson AZ, Orange CA, Houston TX, Omaha NE,
Sponsor: RayzeBio, Inc.

Sex: All

Age: 18+

Code: NCT06726161

Phase1, Phase2, Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC

for
Non-squamous Non-small Cell Lung Cancer
Location: Phoenix AZ, San Diego CA, Redlands CA, Loma Linda CA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06627647

Phase3, Recruiting

Efficacy of iLid Cleanser (Avenova) Versus Vehicle on Ocular Skin Flora

for
Sebaceous Gland Diseases, Blepharitis
Location: Phoenix AZ, San Leandro CA, Winston Salem NC
Sponsor: NovaBay Pharmaceuticals, Inc.

Sex: All

Age: 6+

Code: NCT02455895

Recruiting

EDX110 Randomized Control Trial for Treatment of DFUs

for
Wound Heal, Diabetic Foot Ulcer
Location: Phoenix AZ, Vista CA, Santa Ana CA, McAllen TX
Sponsor: ConvaTec Inc.

Sex: All

Age: 18 - 70+

Code: NCT07209358

Recruiting

A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis

for
Systemic Sclerosis (SSc)
Location: Phoenix AZ, Los Angeles CA, New Orleans LA, Chicago IL,
Sponsor: argenx

Sex: All

Age: 18+

Code: NCT06655155

Phase2, Recruiting

Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)

for
Complex Regional Pain Syndrome Type I
Location: Phoenix AZ, Tucson AZ, La Jolla CA, Tustin CA,
Sponsor: Ambros Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07210515

Phase3, Recruiting

Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis

for
Plaque Psoriasis
Location: Phoenix AZ, San Diego CA, Santa Ana CA,
Sponsor: Oruka Therapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07474792

Phase2, Recruiting

Miro3D Wound Matrix for Treatment of Diabetic Foot Ulcers

for
Diabetic Foot Ulcers (DFUs), Diabetic Foot, Chronic Wounds
Location: Phoenix AZ, Houston TX, Humble TX, Columbus OH,
Sponsor: Reprise Biomedical, Inc.

Sex: All

Age: 18+

Code: NCT07632001

Recruiting
New

A Study of the Preliminary Efficacy of DARE-HPV to Treat High-risk Persistent Human Papillomavirus (hrHPV)

for
Human Papilloma Virus (HPV),
Location: Phoenix AZ, Layton UT, Seattle WA, Little Rock AR
Sponsor: Daré Bioscience, Inc.

Sex: Female

Age: 22 - 50

Code: NCT07601074

Phase2, Recruiting

Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain

for
Chemotherapy Induced Neuropathic Pain,
Location: Phoenix AZ, Glendale AZ, Las Vegas NV,
Sponsor: Dogwood Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT06848348

Phase2, Recruiting

Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387

for
Pericarditis, Pericarditis Acute, Recurrent Pericarditis
Location: Gilbert AZ, Phoenix AZ, Los Angeles CA, Santa Monica CA,
Sponsor: Kiniksa Pharmaceuticals International, plc

Sex: All

Age: 18 - 70+

Code: NCT07010159

Phase2, Phase3, Recruiting